 | Sirolimus blocks this pathway. The safety and efficacy of sirolimus treatment of LAM were investigated in clinical trials that compared sirolimus treatment... 68 KB (6,700 words) - 21:46, 24 April 2024 |
currently the only sirolimus-coated balloon globally approved with CE certification. It is the most clinically studied sirolimus-coated balloon for peripheral... 14 KB (1,375 words) - 21:32, 12 March 2024 |
 | Lymphangioma (section Sirolimus) systemic medication, or through observation. Sirolimus is used to treat lymphangioma. Treatment with sirolimus can decrease pain and the fullness of venous... 21 KB (2,399 words) - 07:31, 9 April 2024 |
 | Medical developed MagicTouch, the world’s first sirolimus-drug coated balloon (SCB). It is the only sirolimus-coated balloon globally approved with CE certification... 6 KB (540 words) - 02:14, 12 February 2024 |
 | Immunosuppressive drug (section Sirolimus) Everolimus is an analog of sirolimus and also is an mTOR inhibitor. Zotarolimus is a semi-synthetic derivative of sirolimus used in drug-eluting stents... 29 KB (3,309 words) - 04:27, 30 January 2024 |
 | medications (dapsone, sulfasalazine), immunosuppressants (cyclosporin, sirolimus) or other medications like omalizumab can be used. These options are explained... 50 KB (5,738 words) - 12:25, 5 May 2024 |
 | needed] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR)... 27 KB (2,534 words) - 23:12, 30 March 2024 |
 | and Drug Administration (FDA) were sirolimus-eluting stents (SES), which release a natural product called sirolimus, an immunosuppressant drug. SES were... 136 KB (13,977 words) - 10:43, 5 April 2024 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 57 KB (5,140 words) - 04:43, 3 April 2024 |
 | MTOR inhibitors (section Sirolimus) sites for mTOR and FKBP12. The bacterial natural product rapamycin or sirolimus, a cytostatic agent, has been used in combination therapy with corticosteroids... 57 KB (6,276 words) - 20:45, 9 May 2024 |
provide a "scaffold" to open the artery. An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals... 2 KB (178 words) - 20:25, 12 March 2024 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 23 KB (2,055 words) - 07:13, 14 March 2024 |
 | hypomagnesemia, hyperglycemia, diabetes mellitus, itching, lung damage (sirolimus also causes lung damage), and various neuropsychiatric problems such as... 43 KB (4,357 words) - 07:40, 28 March 2024 |
 | after, in particular, high-dose therapy. Immunosuppressive drugs, such as sirolimus, mycophenolate mofetil, tacrolimus, ciclosporin, leflunomide and TNF inhibitors... 9 KB (828 words) - 17:16, 9 May 2024 |
 | (mTORC1) led to successful use of rapamycin analog sirolimus in clinical trials and FDA approval of sirolimus for treatment of LAM. TSC1 and TSC2 form a tumor... 100 KB (11,094 words) - 11:12, 6 March 2024 |
 | cyclophosphamide, ciclosporin, tacrolimus, everolimus, thymoglobulin and sirolimus. Newer, so-called "biologic drugs" or monoclonal antibodies, are also... 24 KB (2,769 words) - 03:46, 31 March 2024 |
 | substances that have been studied for GvHD treatment include, for example: sirolimus, pentostatin, etanercept, and alemtuzumab. In August 2017, the US FDA... 37 KB (4,234 words) - 23:18, 18 January 2024 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 171 KB (15,828 words) - 01:00, 9 May 2024 |
 | Sirolimus, a compound that inhibits mTOR signalling, is being studied to treat plexiform neurofibromas. The combination of erlotinib with sirolimus was... 30 KB (3,257 words) - 16:02, 28 February 2024 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 47 KB (4,718 words) - 23:03, 17 April 2024 |
 | cyclophosphamide, mycophenolate, intravenous immunoglobulin, rituximab, sirolimus, alefacept, and the tyrosine kinase inhibitors, imatinib, nilotinib, and... 38 KB (3,291 words) - 01:18, 9 May 2024 |
2018). "Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre... 12 KB (908 words) - 23:10, 16 November 2023 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 134 KB (13,937 words) - 19:09, 8 May 2024 |
usually caused by the prolonged use of T cell suppressant drugs, such as sirolimus, tacrolimus, or ciclosporin. The Epstein-Barr virus, which infects >90%... 7 KB (767 words) - 14:49, 28 March 2024 |
 | hygroscopicus can be used to produce several chemical compounds or enzymes. Sirolimus (also known as rapamycin) is an immunosuppressant that has been isolated... 4 KB (298 words) - 13:29, 17 July 2023 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 6 KB (467 words) - 01:16, 2 May 2024 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 41 KB (3,748 words) - 08:27, 27 April 2024 |
 | drug-eluting stents to be utilized were the paclitaxel-eluting stent and the sirolimus-eluting stent, both of which have received approval from the U.S. Food... 48 KB (5,366 words) - 05:44, 1 April 2024 |
 | triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide Sulfisoxazole Suramin... 25 KB (2,328 words) - 07:02, 24 March 2024 |
 | after transplantation and on detection of CAV. Medications including sirolimus and everolimus can slow disease progression. A repeat heart transplantation... 21 KB (1,955 words) - 14:52, 15 September 2023 |